A critical role of interleukin-1 in preterm labor

dc.contributor.authorNadeau-Vallée, M.
dc.contributor.authorObari, D.
dc.contributor.authorQuiniou, C.
dc.contributor.authorLubell, W.D.
dc.contributor.authorOlson, D.M.
dc.contributor.authorGirard, S.
dc.contributor.authorChemtob, S.
dc.date.issued2016
dc.description.abstractPreterm birth (PTB) is a leading cause of neonatal mortality and morbidity worldwide, and represents a heavy economic and social burden. Despite its broad etiology, PTB has been firmly linked to inflammatory processes. Pro-inflammatory cytokines are produced in gestational tissues in response to stressors and can prematurely induce uterine activation, which precedes the onset of preterm labor. Of all cytokines implicated, interleukin (IL)-1 has been largely studied, revealing a central role in preterm labor. However, currently approved IL-1-targeting therapies have failed to show expected efficacy in pre-clinical studies of preterm labor. Herein, we (a) summarize animal and human studies in which IL-1 or IL-1-targeting therapeutics are implicated with preterm labor, (b) focus on novel IL-1-targeting therapies and diagnostic tests, and (c) develop the case for commercialization and translation means to hasten their development.
dc.description.statementofresponsibilityMathieu Nadeau-Vallée, Dima Obari, Christiane Quiniou, William D.Lubell, David M.Olson, Sylvie Girard, Sylvain Chemtob
dc.identifier.citationCytokine and Growth Factor Reviews, 2016; 28:37-51
dc.identifier.doi10.1016/j.cytogfr.2015.11.001
dc.identifier.issn1359-6101
dc.identifier.issn1879-0305
dc.identifier.urihttp://hdl.handle.net/2440/119887
dc.language.isoen
dc.publisherElsevier
dc.rights© 2015 Elsevier Ltd. All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.cytogfr.2015.11.001
dc.subjectPreterm birth; Preterm labor; interleukin-1; inflammation; infection
dc.titleA critical role of interleukin-1 in preterm labor
dc.typeJournal article
pubs.publication-statusPublished

Files